Clinical Trials Browser

Phase 1 × Chromosome Aberrations × Other hematologic neoplasm × Clear all

NCT02403310 2022-10-03

A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML

Phase 1 Completed

Other hematologic neoplasm

Chromosome Aberrations, Leukemia, Leukemia, Myeloid, Acute

NCT01242774 2020-12-19

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Phase 1 Completed

Other hematologic neoplasm

Chromosome Aberrations, Leukemia, Myeloid, Acute